Overview
Brucella antibodies are produced by the immune system in response to infection with Brucella species, which cause brucellosis, a chronic febrile zoonotic disease. The most common species infecting humans are Brucella abortus and Brucella melitensis. Serological testing for Brucella antibodies is widely used because the organism is slow-growing and culture may be time-consuming or hazardous. Detection of IgM, IgG, and IgA antibodies helps in diagnosing brucellosis, assessing disease stage, and monitoring treatment response.
Symptoms
Brucellosis commonly presents with prolonged or intermittent fever, chills, night sweats, fatigue, and weakness. Musculoskeletal symptoms such as arthralgia, myalgia, and back pain are frequent. Patients may also experience weight loss, anorexia, headache, and malaise. In chronic cases, symptoms may persist for months or years and include hepatosplenomegaly, depression, and neurological complaints. The clinical presentation can be acute, subacute, or chronic, making laboratory support essential for diagnosis.
Causes
Brucella antibody positivity is caused by infection with Brucella organisms transmitted from animals to humans. Infection occurs through consumption of unpasteurized milk and dairy products, direct contact with infected animals, inhalation of contaminated aerosols, or occupational exposure in farmers, veterinarians, and laboratory workers. After infection, IgM antibodies appear early, followed by IgG and IgA antibodies, which may persist for long periods. Serological tests such as Rose Bengal Plate Test, Standard Agglutination Test, Coombs anti-Brucella test, ELISA, and EIA are used to detect these antibodies.
Risk Factors
Risk factors for Brucella antibodies include consumption of unpasteurized milk or dairy products, close contact with livestock such as cattle, goats, sheep, and pigs, and occupational exposure in high-risk professions. Living in or traveling to endemic areas increases susceptibility. Immunocompromised individuals and those with repeated exposure to animals or animal products are at higher risk. Cross-reactivity with other bacterial infections may also influence antibody test results.
Prevention
Prevention of brucellosis focuses on controlling infection in animals and reducing human exposure. Consumption of pasteurized milk and dairy products, use of protective equipment when handling animals, and adherence to laboratory safety measures reduce risk. Early diagnosis using Brucella antibody testing allows timely treatment and prevents complications and chronic disease. Screening of high-risk occupational groups and proper follow-up of treated patients help limit disease burden and recurrence.
